Bank of America’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.4M | Buy |
198,505
+36,002
| +22% | +$8.07M | ﹤0.01% | 1667 |
|
|
2025
Q4 | $34.7M | Buy |
162,503
+14,491
| +10% | +$2.99M | ﹤0.01% | 1831 |
|
|
2025
Q3 | $29.4M | Buy |
148,012
+50,194
| +51% | +$9.36M | ﹤0.01% | 2213 |
|
|
2025
Q2 | $16.9M | Sell |
97,818
-40,074
| -29% | -$6.53M | ﹤0.01% | 2728 |
|
|
2025
Q1 | $21.5M | Buy |
137,892
+111,509
| +423% | +$15.9M | ﹤0.01% | 2360 |
|
|
2024
Q4 | $3.63M | Sell |
26,383
-86,189
| -77% | -$11.3M | ﹤0.01% | 3887 |
|
|
2024
Q3 | $16.8M | Sell |
112,572
-134,389
| -54% | -$18.1M | ﹤0.01% | 2567 |
|
|
2024
Q2 | $33.7M | Sell |
246,961
-17,484
| -7% | -$2.38M | ﹤0.01% | 1774 |
|
|
2024
Q1 | $40M | Buy |
264,445
+112,607
| +74% | +$16.1M | ﹤0.01% | 1648 |
|
|
2023
Q4 | $19.1M | Sell |
151,838
-95,688
| -39% | -$9.54M | ﹤0.01% | 2201 |
|
|
2023
Q3 | $23.2M | Sell |
247,526
-23,165
| -9% | -$2.17M | ﹤0.01% | 1883 |
|
|
2023
Q2 | $24.2M | Buy |
270,691
+250,700
| +1,254% | +$21.8M | ﹤0.01% | 1854 |
|
|
2023
Q1 | $2.14M | Sell |
19,991
-9,817
| -33% | -$1.12M | ﹤0.01% | 4292 |
|
|
2022
Q4 | $3.64M | Buy |
29,808
+9,192
| +45% | +$1.07M | ﹤0.01% | 3704 |
|
|
2022
Q3 | $2.13M | Buy |
20,616
+2,636
| +15% | +$250K | ﹤0.01% | 4209 |
|
|
2022
Q2 | $1.67M | Buy |
17,980
+2,237
| +14% | +$211K | ﹤0.01% | 4460 |
|
|
2022
Q1 | $1.85M | Buy |
15,743
+5,043
| +47% | +$584K | ﹤0.01% | 4669 |
|
|
2021
Q4 | $1.44M | Sell |
10,700
-4,368
| -29% | -$650K | ﹤0.01% | 4896 |
|
|
2021
Q3 | $2.4M | Sell |
15,068
-54
| -0.4% | -$7.39K | ﹤0.01% | 4266 |
|
|
2021
Q2 | $1.99M | Buy |
15,122
+4,215
| +39% | +$562K | ﹤0.01% | 4317 |
|
|
2021
Q1 | $1.41M | Buy |
10,907
+4,884
| +81% | +$742K | ﹤0.01% | 4536 |
|
|
2020
Q4 | $1M | Buy |
6,023
+1,495
| +33% | +$247K | ﹤0.01% | 4505 |
|
|
2020
Q3 | $698K | Buy |
4,528
+846
| +23% | +$122K | ﹤0.01% | 4474 |
|
|
2020
Q2 | $544K | Sell |
3,682
-13,358
| -78% | -$1.83M | ﹤0.01% | 4547 |
|
|
2020
Q1 | $1.92M | Buy |
17,040
+5,458
| +47% | +$709K | ﹤0.01% | 3513 |
|
|
2019
Q4 | $1.61M | Sell |
11,582
-3,916
| -25% | -$435K | ﹤0.01% | 4177 |
|
|
2019
Q3 | $1.49M | Sell |
15,498
-6,637
| -30% | -$740K | ﹤0.01% | 4273 |
|
|
2019
Q2 | $2.55M | Buy |
22,135
+1,847
| +9% | +$221K | ﹤0.01% | 3846 |
|
|
2019
Q1 | $2.39M | Buy |
20,288
+5,790
| +40% | +$507K | ﹤0.01% | 3842 |
|
|
2018
Q4 | $908K | Sell |
14,498
-39,632
| -73% | -$2.49M | ﹤0.01% | 4486 |
|
|
2018
Q3 | $3.83M | Buy |
54,130
+22,317
| +70% | +$1.54M | ﹤0.01% | 3444 |
|
|
2018
Q2 | $2.12M | Buy |
31,813
+27,303
| +605% | +$1.8M | ﹤0.01% | 3939 |
|
|
2018
Q1 | $295K | Sell |
4,510
-5,709
| -56% | -$321K | ﹤0.01% | 5161 |
|
|
2017
Q4 | $409K | Buy |
10,219
+5,789
| +131% | +$210K | ﹤0.01% | 5064 |
|
|
2017
Q3 | $160K | Sell |
4,430
-392
| -8% | -$11.2K | ﹤0.01% | 5485 |
|
|
2017
Q2 | $134K | Sell |
4,822
-523
| -10% | -$13.8K | ﹤0.01% | 5489 |
|
|
2017
Q1 | $150K | Buy |
5,345
+1,020
| +24% | +$25.8K | ﹤0.01% | 5443 |
|
|
2016
Q4 | $88K | Buy |
4,325
+1,100
| +34% | +$22K | ﹤0.01% | 5688 |
|
|
2016
Q3 | $65K | Sell |
3,225
-48,031
| -94% | -$793K | ﹤0.01% | 5624 |
|
|
2016
Q2 | $680K | Buy |
51,256
+28,945
| +130% | +$446K | ﹤0.01% | 4449 |
|
|
2016
Q1 | $414K | Buy |
22,311
+1,452
| +7% | +$25.8K | ﹤0.01% | 4705 |
|
|
2015
Q4 | $382K | Buy |
20,859
+1,804
| +9% | +$31.6K | ﹤0.01% | 4982 |
|
|
2015
Q3 | $337K | Sell |
19,055
-225
| -1% | -$4.38K | ﹤0.01% | 5050 |
|
|
2015
Q2 | $341K | Buy |
19,280
+2,388
| +14% | +$41.8K | ﹤0.01% | 4963 |
|
|
2015
Q1 | $293K | Buy |
+16,892
| New | +$307K | ﹤0.01% | 4681 |
|
Other funds holding ASND
RCM
ACA
